Fatma Hümeyra YERLİKAYA, Aysun TOKER, YEŞİM YENER

Effects of acrylamide treatment on oxidant and antioxidant levels in rats

Bu çalışmada, uzun süre akrilamid verilen sıçanlar üzerinde total antioksidan durum (TAS), total oksidan durum (TOS) ve iskemi modifiye albuminin (IMA) serum düzeylerinin nasıl değiştiğinin araştırılması amaçlanmıştır. Çalışmada 65-75 g ağırlığında ve yaşları 3-4 haftalık 25 erkek ve 25 dişi Wistar cinsi sıçanlar kullanılmıştır. Hayvanlar 90 gün boyunca standart sıçan yemi ile beslenmişlerdir. Bununla beraber, günlük tüketecekleri içme suyuna 2 mg/kg/gün ve 5 mg/kg/gün dozunda akrilamid ilave edilmiştir. Akrilamid uygulaması sonrası hayvanlar anestezi altında servikal dislokasyonla öldürülmüş ve serumlarında IMA, TAS, TOS ve albumin düzeyleri spektrofotometrik yöntem ile ölçülmüştür. 2 mg/kg ve 5mg/kg akrilamid verilen erkek sıçanlara ait serum IMA düzeyleri kontrol grubuna göre önemli derecede yüksek bulunmuştur. Ayrıca, 5mg/kg akrilamid verilen erkek sıçanlara ait serum TAS düzeyleri kontrol grubuna göre önemli derecede düşük ve serum TOS değerleri önemli derecede yüksek bulunmuştur. 2 mg/kg ve 5mg/kg akrilamid verilen dişi sıçanlara ve kontrol grubuna ait serum IMA, TAS, TOS ve albumin düzeyleri arasında istatistiki açıdan önemli bir fark bulunamamıştır. Bu sonuçlara bağlı olarak bulgularımız, akrilamidin oksidatif stresi artırdığını göstermektedir.

Ratlarda Akrilamid Kullanımının Antioksidan ve Oksidan Değerleri Üzerine Etkisi

The aim of this study was to investigate serum total antioxidant status (TAS), total oxidant status (TOS) and ischemia-modified albumin (IMA) levels in long term acrylamide (ACR) given rats, compared to control rats. In total, 25 male and 25 female Wistar rats were involved in this experiment. Animals in each sex were segregated into three groups. Two of them were treatment groups and one of them was control group. Each treatment group consisted of ten animals and each control group consisted of five animals. ACR was administered to the treatment groups at 2 and 5 mg/kg/day via drinking water for 90 days. In the end of the experiment, serum samples were analyzed for IMA, TAS, TOS and albumin levels with the spectrophotometric method. Serum IMA and adjusted IMA levels were significantly higher at concentrations of 2 mg/kg and 5 mg/kg in the male rats when compared with those of the control male rats. Serum TAS levels significantly decreased at concentrations of 5 mg/kg in the male rats when compared with those of the control rats. We also observed a significant increase in the levels of serum TOS at concentrations of 5 mg/kg in the male rats. There were no significant differences between serum IMA, TAS, TOS and albumin levels at concentrations of 2 mg/kg and 5 mg/kg in the female rats. Our findings show that long term treatment with 2 mg/kg and 5 mg/kg doses of ACR led to a significant depletion of serum TAS levels and overproduction of serum TOS and IMA levels, consequently, to an increase in oxidative stress.

PDF

___

1. Hogervorst JG, Schouten LJ, Konings EJ, Goldbohm RA, van den Brandt PA: Dietary acrylamide intake and the risk of renal cell, bladder, and prostate cancer. Am J Clin Nutr, 87 (5): 1428-1438, 2008.
2. Dearfield KL, Abernathy CO, Ottley MS, Brantner JH, Hayes PF: Acrylamide: Its metabolism, developmental and reproductive effects, genotoxicity, and carcinogenicity. Mutat Res, 195 (1): 45-77, 1988.
3. Tareke E, Rydberg P, Karlsson P, Eriksson S, Törnqvist M: Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J Agric Food Chem, 50 (17): 4998-5006, 2002.
4. Becalski A, Lau BP, Lewis D, Seaman SW, Hayward S, Sahagian M, Ramesh M, Leclerc Y: Acrylamide in French fries: Influence of free amino acids and sugars. J Agric Food Chem, 52 (12): 3801-3806, 2004.
5. Mottram DS, Wedzicha BL, Dodson AT: Acrylamide is formed in the Maillard reaction. Nature, 419, 448-449, 2002.
6. Stadler RH, Robert F, Riediker S, Varga N, Davidek T, Devaud S, Goldmann T, Hau J, Blank I: In-depth mechanistic study on the formation of acrylamide and other vinylogous compounds by the Maillard reaction. J Agr Food Chem, 52, 5550-5558, 2004.
7. Yaylayan VA, Wnorowski A, Locas CP: Why asparagine needs carbohydrates to generate acrylamide. J Agr Food Chem, 51, 1753-1757, 2003.
8. Zyzak DV, Sanders RA, Stojanovic M, Tallmadge DH, Eberhart BL, Ewald DK, Gruber DC, Morsch TR, Strothers MA, Rizzi GP, Villagran MD: Acrylamide formation mechanism in heated foods. J Agr Food Chem, 51, 4782-4787, 2003.
9. Granvogl M, Jezussek M, Koehler P, Schieberle P: Quantitation of 3-aminopropionamide in potatoes - A minor but potent precursor in acrylamide formation. J Agr Food Chem, 52, 4751-4757, 2004.
10. Besaratinia A, Pfeifer GP: A review of mechanisms of acrylamide carcinogenicity. Carcinogenesis, 28 (3): 519-528, 2007.
11. Rodríguez-Ramiro I, Martín MÁ, Ramos S, Bravo L, Goya L: Olive oil hydroxytyrosol reduces toxicity evoked by acrylamide in human Caco-2 cells by preventing oxidative stress. Toxicology, 288 (1-3): 43-48, 2011.
12. Trevisan M, Browne R, Ram M, Muti P, Freudenheim J, Carosella AM, Armstrong D: Correlates of markers of oxidative status in the general population. Am J Epidemiol, 154 (4): 348-356, 2001.
13. Zhu YJ, Zeng T, Zhu YB, Yu SF, Wang QS, Zhang LP, Guo X, Xie KQ: Effects of acrylamide on the nervous tissue antioxidant system and sciatic nerve electrophysiology in the rat. Neurochem Res, 33 (11): 2310-2317, 2008.
14. Erel O: A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem, 37 (2): 112-119, 2004.
15. Erel O: A new automated colorimetric method for measuring total oxidant status. Clin Biochem, 38 (12): 1103-1111, 2005.
16. Catalgol B, Ozhan G, Alpertunga B: Acrylamide-induced oxidative stress in human erythrocytes. Hum Exp Toxicol, 28 (10): 611-617, 2009.
17. Bar-Or D, Lau E, Winkler JV: A novel assay for cobalt-albumin binding and its potential as marker its potential as a marker for myocardial ischemia-A preliminary report. J Emer Med, 19, 311-315, 2000.
18. Roy D, Quiles J, Gaze DC, Collinson P, Kaski JC, Baxter GF: Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart, 92 (1): 113-114, 2006.
19. Sbarouni E, Georgiadou P, Voudris V: Ischemia modified albumin changes - review and clinical implications. Clin Chem Lab Med, 49, 177-184, 2011.
20. Burek JD, Albee RR, Beyer JE, Bell TJ, Carreon RM, Morden DC, Wade CE, Hermann EA, Gorzinski SJ: Subchronic toxicity of acrylamide administered to rats in drinking water follewed by up to 144 days of recovery. J Environ Pathol Toxicol, 4, 157-182, 1980.
21. Smith MK, Zenick H, Preston RJ, George EL, Long RE: Dominant lethal effects of subchronic acrylamide administration in the male Long-Evans rat. Mutat Res, 173, 273-277, 1986.
22. Lippi G, Montagnana M, Salvagno GL, Guidi GC: Standardization of ischaemia-modified albumin testing: Adjustment for serum albumin. Clin Chem Lab Med, 45 (2): 261-262, 2007.
23. Gutteridge JM, Halliwell B: Free radicals and antioxidants in the year 2000. A historical look to the future. Ann N Y Acad Sci, 899, 136-147, 2000.
24. Jiang L, Cao J, An Y, Geng C, Qu S, Jiang L, Zhong L: Genotoxicity of acrylamide in human hepatoma G2 (HepG2) cells. Toxicol In Vitro, 21 (8): 1486-1492, 2007.
25. Odland L, Romert L, Clemedson C, Walum E: Glutathione content, glutathione transferase activity and lipid peroxidation in acrylamide-treated neuroblastoma N1E 115 cells. Toxicol In Vitro, 8 (2): 263-267, 1994.
26. Conklin KA: Dietary antioxidants during cancer chemotherapy: Impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer, 37 (1): 1-18, 2000.
27. Awad ME, Abdel-Rahman MS, Hassan SA: Acrylamide toxicity in isolated rat hepatocytes. Toxicol In Vitro, 12 (6): 699-704, 1998.
28. Yousef MI, El-Demerdash FM: Acrylamide-induced oxidative stress and biochemical perturbations in rats. Toxicology, 219 (1-3): 133-141, 2006.
29. Allam A, El-Ghareeb AA, Abdul-Hamid M, Baikry A, Sabri MI: Prenatal and perinatal acrylamide disrupts the development of cerebellum in rat: Biochemical and morphological studies. Toxicol Ind Health, 27 (4): 291-306, 2011.
30. Alturfan AA, Tozan-Beceren A, Sehirli AO, Demiralp E, Sener G, Omurtag GZ: Resveratrol ameliorates oxidative DNA damage and protects against acrylamide-induced oxidative stress in rats. Mol Biol Rep, 39 (4): 4589-4596, 2011;
31. Edwards SW, Hallett MB, Campbell AK: Oxygen-radical production during inflammation may be limited by oxygen concentration. Biochem J, 217, 851-854, 1984.
32. Naruszewicz M, Zapolska-Downar D, Kośmider A, Nowicka G, Kozłowska-Wojciechowska M, Vikström AS, Törnqvist M: Chronic intake of potato chips in humans increases the production of reactive oxygen radicals by leukocytes and increases plasma C-reactive protein: A pilot study. Am J Clin Nutr, 89 (3): 773-777, 2009.
33. Sinha MK, Gaze DC, Tippins JR, Collinson PO, Kaski JC: Ischemia-modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation, 107, 2403-2405, 2003.
34. Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC: Role of ischemia- modified albumin a new biochemical marker of myocardial ischemia, in the early diagnosis of acute coronary syndromes. Emerg Med J, 21, 29-34, 2004.
35. Pialoux V, Brown AD, Leigh R, Friedenreich CM, Poulin MJ: Effect of cardiorespiratory fitness on vascular regulation and oxidative stress in postmenopausal women. Hypertension, 54 (5): 1014-1020, 2009.
36. Park HR, Kim MS, Kim SJ, Park M, Kong KH, Kim HS, Kwack SJ, Kang TS, Kim SH, Kim HS, Lee J: Acrylamide induces cell death in neural progenitor cells and impairs hippocampal neurogenesis. Toxicol Lett, 193 (1): 86-93, 2010.
37. Bowyer JF, Latendresse JR, Delongchamp RR, Warbritton AR, Thomas M, Divine B, Doerge DR: The mRNA expression and histological integrity in rat forebrain motor and sensory regions are minimally affected by acrylamide exposure through drinking water. Toxicol Appl Pharmacol, 240 (3): 401-411, 2009.
38. Raju J, Sondagar C, Roberts J, Aziz SA, Caldwell D, Vavasour E, Mehta R: Dietary acrylamide does not increase colon aberrant crypt foci formation in male F344 rats. Food Chem Toxicol, 49 (6): 1373-1380, 2011.